In April 2024, the Clinical Laboratory Improvement Advisory Committee (CLIAC) acknowledged the need for ethical artificial intelligence (AI) integration to influence the prevention of medical bias and to protect patient data, among other potential uses. CLIAC also recommended the support of data scientists and experts familiar with AI approaches to advise clinical laboratories as AI algorithms are... Read more
In the June issue of MedicalLab Management we covered the initial lead up to expanding and refining testing for THC compounds in the clinical laboratory. This was initiated as a process improvement collaboration with the behavioral medicine group. Visit medlabmag.com/article/2064 to review Part 1 of this 2-part series: THC QA Informs Validation
Part 1 of this series discusses the essential role... Read more
Blood cultures remain the gold standard for diagnosing bloodstream infections, including sepsis and bacteremia.1,2 However, the reliability of blood culture results is largely dependent on a low rate of blood culture contamination, which most commonly originates from the presence of commensal organisms on the patient’s skin during the collection process and can contribute to increased lengths... Read more
Point-of-care testing (POCT) devices are now utilized in a range of settings both internal and external to the laboratory and are characterized as handheld or having a small footprint to accommodate non-lab settings. Handheld tests include visually read lateral flow immunoassay tests and other qualitative test strips, such as blood glucose testing devices.
Benchtop POCT devices generally enable more... Read more
www.medlabmag.com uses tracking technologies. The site may also
include cookies from third parties. By continuing to use this website, you consent
to the use of tracking technologies as defined in our
Privacy Policy that can be read by clicking here.